Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 1
2007 1
2008 1
2009 1
2011 2
2013 3
2014 1
2016 1
2020 2
2021 7
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Targeting galectin-3 in inflammatory and fibrotic diseases.
Bouffette S, Botez I, De Ceuninck F. Bouffette S, et al. Among authors: de ceuninck f. Trends Pharmacol Sci. 2023 Aug;44(8):519-531. doi: 10.1016/j.tips.2023.06.001. Epub 2023 Jun 28. Trends Pharmacol Sci. 2023. PMID: 37391294 Free article. Review.
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.
Ortega-Ferreira C, Soret P, Robin G, Speca S, Hubert S, Le Gall M, Desvaux E, Jendoubi M, Saint-Paul J, Chadli L, Chomel A, Berger S, Nony E, Neau B, Fould B, Licznar A, Levasseur F, Guerrier T, Elouej S, Courtade-Gaïani S, Provost N, Nguyen TQ, Verdier J, Launay D, De Ceuninck F. Ortega-Ferreira C, et al. Among authors: de ceuninck f. Nat Commun. 2023 Aug 31;14(1):5291. doi: 10.1038/s41467-023-41117-9. Nat Commun. 2023. PMID: 37652913 Free PMC article.
Access to Galectin-3 Inhibitors from Chemoenzymatic Synthons.
Dussouy C, Téletchéa S, Lambert A, Charlier C, Botez I, De Ceuninck F, Grandjean C. Dussouy C, et al. Among authors: de ceuninck f. J Org Chem. 2020 Dec 18;85(24):16099-16114. doi: 10.1021/acs.joc.0c01927. Epub 2020 Nov 17. J Org Chem. 2020. PMID: 33200927
Proteomics: addressing the challenges of osteoarthritis.
De Ceuninck F, Berenbaum F. De Ceuninck F, et al. Drug Discov Today. 2009 Jul;14(13-14):661-7. doi: 10.1016/j.drudis.2009.05.006. Epub 2009 May 27. Drug Discov Today. 2009. PMID: 19477289 Review.
Structure-Activity Relationship of Azaindole-Based Glucokinase Activators.
Paczal A, Bálint B, Wéber C, Szabó ZB, Ondi L, Theret I, De Ceuninck F, Bernard C, Ktorza A, Perron-Sierra F, Kotschy A. Paczal A, et al. Among authors: de ceuninck f. J Med Chem. 2016 Jan 28;59(2):687-706. doi: 10.1021/acs.jmedchem.5b01594. Epub 2016 Jan 15. J Med Chem. 2016. PMID: 26685731
Applications of transcriptomics in support of drug development for osteoarthritis.
Kaplon H, Luo Y, De Ceuninck F, Lalande A, Courtade-Gaiani S, Laigle L, Moingeon P. Kaplon H, et al. Among authors: de ceuninck f. Osteoarthr Cartil Open. 2021 Nov 18;3(4):100221. doi: 10.1016/j.ocarto.2021.100221. eCollection 2021 Dec. Osteoarthr Cartil Open. 2021. PMID: 36474760 Free PMC article.
30 results